Client Login Portal
    • addthis
    • link : Client Login
    • knowledge network
    • Practice Areas
    • Cases
    • About Us
    • News & Events
    • Our People
    • Knowledge Network
    • Contact Us
    Labaton Sucharow
    • addthis
    • link : Client Login
    • knowledge network
    • Practice Areas
    • Cases
    • About Us
    • News & Events
    • Our People
    • Knowledge Network
    • Contact Us
    • Practice Areas
    • Cases
    • About Us
    • News & Events
    • Our People
    • Contact Us
    • Knowledge Network
    • Client Login
    • Search
    • addthis
    • link : Client Login
    • knowledge network
    Labaton Sucharow
    • News & Events
      • Press Room
      • Published
      • Events
    • Digital Library
      • Videos
      • Podcasts
      • Webinars
    • News & Events
      • Press Room
      • Published
      • Events
      • The Liaison
    • Digital Library
      • Videos
      • Podcasts
      • Webinars

    AbbVie Faces 1st Antitrust Suit Over Humira 'Patent Thicket'

    Law360
    March 18, 2019

    Law360 and other legal and pharmaceutical publications wrote about our "first-of-its-kind" lawsuit alleging AbbVie and several biosimilar makers engaged in anticompetitive conduct to block competition for AbbVie's Humira, which is the world' top-selling drug.  The suit was filed on behalf of UFCW Local 1500 Welfare Fund.  Labaton Sucharow's Antitrust and Competition Litigation Co-Chair Gregory Asciolla told Law360 that the suit is "the first class action filed regarding these claims." 

    Additional Coverage

    AbbVie Hit with Class-Action Lawsuit Over its 'Patent Estate' to Protect Humira
    Becker’s Hospital Review, March 19, 2019

    AbbVie Sued for Alleged Antitrust Violations Over Blockbuster Med Humira
    Law.com, March 19, 2019

    Class Action Lawsuit Filed Against AbbVie and Biosimilar Developers Alleges Collusion
    The Center for Biosimilars, March 19, 2019

    AbbVie Faces Class Action Lawsuit from New York Grocery Union Over Humira 'Patent Thicket'
    FiercePharma, March 20, 2019

    AbbVie Is Sued for Using Humira Patent Deal to Block Competition in the U.S. 
    STAT, March 20, 2019

    Useful Links

    • Practice Areas
    • Cases
    • About Us
    • News & Events
    • Our People
    • Knowledge Center

    Our Locations

    footer-list-map_icon New York
    140 Broadway
    New York, NY 10005
    212-907-0700

    footer-list-map_icon Delaware
    222 Delaware Avenue, Suite 1510
    Wilmington, DE 19801
    302-573-2540

    Useful Links

    footer-list-map_icon Washington, D.C.
    1050 Connecticut Avenue, NW, Suite 500
    Washington, D.C. 20036
    212-907-0700

    Stay Connected

    • Facebook
    • Twitter
    • LinkedIn
    Labaton Sucharow
    • Attorney Advertising Disclaimer
    • Privacy Policy
    • Transparency in Coverage Rule
    • labaton.com
    • Labaton Sucharow All Rights Reserved 2023

    Attorney Advertising Disclaimer

    The materials appearing on this website are provided for informational purposes only and do not constitute legal advice. You should not take action based upon this information without consulting legal counsel. This site is not intended to create an attorney-client relationship. The hiring of a lawyer is an important decision that should not be based solely upon any single source of information, including advertising on this website. You may ask us to send you further information about us, and we urge you to review other sources of information about us.